Cargando…

A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort

CanAssist Breast (CAB), a prognostic test uses immunohistochemistry (IHC) approach coupled with artificial intelligence-based machine learning algorithm for prognosis of early-stage hormone-receptor positive, HER2/neu negative breast cancer patients. It was developed and validated in an Indian cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunda, Aparna, Basavaraj, Chetana, Serkad V, Chandra Prakash, Adinarayan, Manjula, Kolli, Ramu, Siraganahalli Eshwaraiah, Mallikarjuna, Saura, Cristina, Ruiz, Fiorella, Gomez, Patricia, Peg, Vicente, Jimenez, Jose, Sprung, Susanne, Fiegl, Heidi, Brunner, Christine, Egle, Daniel, Bhattacharyya, GS, Bakre, Manjiri M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892025/ https://www.ncbi.nlm.nih.gov/pubmed/35245746 http://dx.doi.org/10.1016/j.breast.2022.02.010

Ejemplares similares

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
por: Eshwaraiah, Mallikarjuna Siraganahalli, et al.
Publicado: (2023)

Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
por: Sengupta, Aditya K., et al.
Publicado: (2020)

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
por: Govindan, Sindhu, et al.
Publicado: (2020)

The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin
por: Chandra Doval, Dinesh, et al.
Publicado: (2021)

A comparative analysis of recurrence risk predictions in ER+/HER2− early breast cancer using NHS Nottingham Prognostic Index, PREDICT, and CanAssist Breast
por: Gunda, Aparna, et al.
Publicado: (2022)

Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
por: Attuluri, Arun Kumar, et al.
Publicado: (2019)

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
por: Zhang, Xi, et al.
Publicado: (2023)

Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients
por: Bakre, Manjiri M., et al.
Publicado: (2019)

CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario
por: Sankaran, Satish, et al.
Publicado: (2019)

To Give or Not to Give Adjuvant Chemotherapy in Breast Cancer? Can CanAssist Breast Assist?
por: Akhade, Amol, et al.
Publicado: (2022)

Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer
por: Ramkumar, Charusheila, et al.
Publicado: (2018)

Robust Guidelines for the Management of HR+ Her2− EBC: Crucial Value of CanAssist Breast
por: Vaid, Ashok, et al.
Publicado: (2022)

Cognition enhancing abilities of vitamin D, epalrestat and their combination in diabetic rats with and without scopolamine induced amnesia
por: Kulkarni, Utkarsha D., et al.
Publicado: (2021)

CLINICOPATHOLOGICAL EVALUATION OF NONMELANOMA SKIN CANCER
por: Adinarayan, Manjula, et al.
Publicado: (2011)

Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients
por: Goebel, G, et al.
Publicado: (2012)

Early-Stage Breast Cancer Detection in Breast Milk
por: Saura, Cristina, et al.
Publicado: (2023)

Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer
por: Serna, Garazi, et al.
Publicado: (2020)

Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy
por: Saura, Cristina, et al.
Publicado: (2021)

Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients
por: Wolf, Barbara, et al.
Publicado: (2016)

Is Serum Ferritin an Early Marker for COVID-19-Associated Mucormycosis?
por: DP, Indu, et al.
Publicado: (2023)

The efficacy of diet supplemented with Lepidium sativum (Chandrashoor) on expressed breast milk volume in hypogalactic mothers – An open-label noncross-over randomized trial
por: Ranade, Manjiri, et al.
Publicado: (2021)

Genome Editing in Medicine: Tools and Challenges
por: Petraitytė, Gunda, et al.
Publicado: (2021)

Lymphatic mapping could not be impaired in the presence of breast carcinoma and coexisting small lymphocytic lymphoma
por: Arana, Sebastian, et al.
Publicado: (2013)

A Devastatingly “Minor” Relationship Between Male Breast Cancer and Prostate Cancer
por: Kolli, Sindhura, et al.
Publicado: (2018)

Role of Nuclear Morphometry in Breast Cancer and its Correlation with Cytomorphological Grading of Breast Cancer: A Study of 64 Cases
por: Kashyap, Anamika, et al.
Publicado: (2018)

Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial
por: Fiegl, Michael, et al.
Publicado: (2011)

Gene expression‐based classifications of fibroadenomas and phyllodes tumours of the breast
por: Vidal, Maria, et al.
Publicado: (2015)

Clinical Impact of RANK Signalling in Ovarian Cancer
por: Wieser, Verena, et al.
Publicado: (2019)

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
por: Manjula, Ramu, et al.
Publicado: (2021)

Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer
por: Brasó-Maristany, Fara, et al.
Publicado: (2021)

Targeting PI3KCA pathway to improve patient outcomes in hormone receptor-positive breast cancer: a worthy 20-year wager?
por: Saura, C
Publicado: (2019)

Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response
por: Ciriaco, Nikaoly, et al.
Publicado: (2022)

Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients.
por: Zojer, N., et al.
Publicado: (1997)

EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs
por: James, Roshan, et al.
Publicado: (2012)

Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
por: Balaji, Sai A., et al.
Publicado: (2016)

Oncocytic adenoma of thyroid with papillary architecture: A diagnostic dilemma
por: Deshmukh, Sanjay D., et al.
Publicado: (2015)

Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression Microarray
por: Alshabi, Ali Mohamed, et al.
Publicado: (2019)

Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study
por: Widschwendter, Martin, et al.
Publicado: (2008)

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer
por: Azim, Samira Abdel, et al.
Publicado: (2016)

The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugates
por: Escrivá-de-Romaní, Santiago, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3l68tqkaat4fvqm91jv2tqgbos